Skip to content
Research Article Open access CC BY 4.0

Lecithin: Cholesterol Acyltransferase Activity and Homocysteine Levels are Better Associated with Lipid Profile Indices Compared to Glycemic Control Indices in Patients with Diabetes Mellitus

Manouchehr Nakhjavani, Zaniar Ghazizadeh, Zahra Banihashemi, Negin Abedinzadeh, Arash Aghajani Nargesi, Afsaneh Morteza, Azam Ghaneei, Alireza Esteghamati, Hossein Mirmiranpour

Advances in Research · pp. 49–59 · Published 22 Sep 2014

10.9734/AIR/2015/12410

Abstract

Aims: Homocysteine (Hcy) level, LCAT activity, and HDL-C concentration and oxidative/anti-oxidative capacities are well-established factors in determining cardiovascular disease risk in Type 2 diabetes mellitus. However, the association between these factors and lipid profile and glycemic control variables remains to be unveiled. We aimed to assess accuracy of LCAT activity and Hcy for dyslipidemia and poor glycemic control screening in patients with type 2 diabetes mellitus. Study Design: This case control study was conducted in Vali-Asr hospital affiliated with Tehran University of Medical Sciences. Methodology: We quantified FBS, HDL-C, HbA1c, Hcy, LCAT activity and other lipid profiles markersin a total of 41 patients with type 2 diabetes mellitus along with 41 matched healthy subjects. Results: Linear regression and correlation analysis revealed that Hcy had a positive correlation with LCAT activity only in HDL levels above 40 mg/dl. Receiver operating characteristics (ROC) curves testing LCAT activity in prediction of hyperhomocysteinemia as the state variable for both control subjects and patients, showed the one for patients with diabetes being more shifted up and to the left than for control subjects. In addition, both Hcy and LCAT activity predicted lipid profile variables more precisely than glycemic control variables. Conclusion: LCAT activity could be considered as one of the factors predicting hyperhomocysteinemia and therefore indirectly associated with cardiovascular events and it is more specific and sensitive in patients with diabetes compared to control subjects. However neither Hcy and nor LCAT activity, are able to predict diabetes and/or diabetes associated oxidative stress. These factors might be more associated with diabetes related dyslipidemia.  

Homocysteine lecithin cholesterol acyltransferase high-density lipoprotein, type 2 diabetes mellitus

References (26)

  1. 1 Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins [DOI]
  2. 2 Hyperhomocysteinemia Decreases Circulating High-Density Lipoprotein by Inhibiting Apolipoprotein A-I Protein Synthesis and Enhancing HDL Cholesterol Clearance [DOI]
  3. 3 Abnormal Lipid Metabolism in Cystathionine β-Synthase-deficient Mice, an Animal Model for Hyperhomocysteinemia [DOI]
  4. 4 Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. [DOI]
  5. 5 Hypothesis: Hyperhomocysteinemia is an indicator of oxidant stress [DOI]
  6. 6 Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease [DOI]
  7. 7 Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease [DOI]
  8. 8 Structural modifications of HDL and functional consequences [DOI]
  9. 9 Current understanding of the metabolism and biological actions of HDL [DOI]
  10. 10 Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. [DOI]
  11. 11 Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2 [DOI]
  12. 12 Modified HDL: Biological and physiopathological consequences [DOI]
  13. 13 Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus [DOI]
  14. 14 High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: Possible attenuation of cardioprotection associated with high HDL cholesterol [DOI]
  15. 15 Effect of Folic Acid Supplementation on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis [DOI]
  16. 16 Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL [DOI]
  17. 17 Age, Homocysteine, and Oxidative Stress: Relation to Hypertension and Type 2 Diabetes Mellitus [DOI]
  18. 18 Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease [DOI]
  19. 19 Insulin resistance profile among siblings of type 2 diabetes mellitus (preliminary study).
  20. 20 Homocysteine concentrations and vascular complications in patients with type 2 diabetes [DOI]
  21. 21 Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population [DOI]
  22. 22 ApoA-I [DOI]
  23. 23 Effect of non-enzymatic glycation on aluminium-induced lipid peroxidation of human high density lipoproteins (HDL) [DOI]
  24. 24 Hyperhomocysteinemia: a renal and cardiovascular risk factor? [DOI]
  25. 25 Homocysteine and cardiovascular risk in patients with diabetes mellitus.
  26. 26 Hyperhomocysteinaemia and neuropathy in Type 2 diabetes [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

29

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.